Related Experiment Video
Updated: Aug 15, 2026

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
Published on: December 9, 2021
Endothelial-monocyte activating polypeptide II alters fibronectin based endothelial cell adhesion and matrix assembly
Margaret A Schwarz1, Hiahua Zheng, Jie Liu
1Department of Surgery, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 125 Paterson Street, CAB 7319, New Brunswick, NJ 08903, USA. m.schwarz@umdnj.edu
Abstract:
Mature Endothelial-Monocyte Activating Polypeptide (mEMAP) II functions as a potent antiangiogenic peptide. Although the anti-tumor effect of mEMAP II has been described, little is known regarding its mechanism of action. Observations that mEMAP II induced apoptosis only in a subset of migrating and proliferating endothelial cells (EC) suggests a targeted effect on cells engaged in angiogenic activities which are known to rely upon cell adhesion and migration. Indeed, we demonstrate that mEMAP II inhibited fibronectin (FN) dependent microvascular EC (MEC) adhesion and spreading and we show that this depends upon the alpha5 beta1 integrin. Immunofluorescence analysis demonstrated that mEMAP II-dependent blockade of FN-alpha5 beta1 interactions was associated with disassembly of both actin stress fiber networks and FN matrix. These findings suggest that mEMAP II blocks MEC adhesion and spreading on fibronectin, via a direct interaction with the integrin alpha5 beta1, thus implicating that alpha5 integrin may be a mediator of mEMAP II's antiangiogenic function.
Insights
Mature Endothelial-Monocyte Activating Polypeptide II (mEMAP II) inhibits endothelial cell adhesion and spreading by targeting alpha5 beta1 integrin. This mechanism underlies mEMAP II's anti-angiogenic and potential anti-tumor effects.
Area of Science:
- Molecular Biology
- Cell Biology
- Biochemistry
Background:
- Mature Endothelial-Monocyte Activating Polypeptide II (mEMAP II) is a known anti-angiogenic peptide with poorly understood mechanisms.
- mEMAP II selectively induces apoptosis in migrating and proliferating endothelial cells (EC).
- Angiogenic processes heavily rely on EC adhesion and migration.
Purpose of the Study:
- To elucidate the mechanism of action for mEMAP II's anti-angiogenic properties.
- To investigate the role of cell adhesion molecules in mEMAP II's targeted effects.
- To identify specific molecular targets of mEMAP II in endothelial cells.
Main Methods:
- Assessed mEMAP II's effect on fibronectin (FN)-dependent microvascular EC (MEC) adhesion and spreading.
- Utilized immunofluorescence to analyze interactions between FN, alpha5 beta1 integrin, and cellular structures.
- Investigated the role of the alpha5 beta1 integrin in mediating mEMAP II's cellular effects.
Main Results:
- mEMAP II significantly inhibited FN-dependent MEC adhesion and spreading.
- The inhibitory effect of mEMAP II was dependent on the alpha5 beta1 integrin.
- mEMAP II treatment led to the disassembly of actin stress fibers and the FN matrix.
- mEMAP II directly blocked FN-alpha5 beta1 integrin interactions.
Conclusions:
- mEMAP II inhibits MEC adhesion and spreading on fibronectin through direct interaction with the alpha5 beta1 integrin.
- The alpha5 beta1 integrin is implicated as a key mediator of mEMAP II's anti-angiogenic function.
- Understanding this mechanism provides insight into mEMAP II's anti-tumor potential.
Related Concept Videos
Intracellular Signaling Affects Focal Adhesions
Some...
Fibronectins Connect Cells with ECM
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
Overview of Cell-Matrix Interactions
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Regulation of Angiogenesis and Blood Supply

